Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)

Study:

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung (Excluding Predominant Squamous Cell Histology)

Rationale:

n/a

Purpose:

This is an observational study designed to follow patients with metastatic or locally advanced and unresectable CRC, locally advanced or metastatic NSCLC (excluding predominant squamous histology) who are receiving Avastin in combination with first-line chemotherapy. Second-line metastatic CRC patients are also eligible. Patients who started their Avastin containing therapy <3 months prior to enrollment are eligible.

Study Status: Recruiting

Recruiting:
Mary Poloncarz 216-986-4761 poloncm@ccf.org

Condition Intervention Phase
Colorectal Cancer
Non-Small Cell Lung Cancer
n/a Phase 4

Verified by Genentech March, 2008

Sponsored by: Genentech
Information provided by: Genentech
ClinicalTrials.gov identifier: NCT00388206

Study Type: Interventional

Study Design: Cohort, Prospective

Cleveland Clinic Cancer Center
Independence, Ohio 44131
United States

Mary Sugrue, M.D.., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site